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Abstract
Background: In a non-smoking population exercise and nicotine have been shown to improve
cognition (Guirguis, 2016). In a non-deprived smoking model it is unknown if the exercise will
provide the same benefit seen in non-smokers.
Hypothesis: Post-exercise treatment and post-nicotine treatment there will be an improvement in
cognition but there will be no differences in cognition between treatment conditions.
Methods: Utilizing a randomized counterbalanced crossover study design smokers (N=26)
completed three cognitive assessments. The primary outcome was working memory accuracy
and reaction time (RT) measured by n-back assessments (i.e., 3-back).
Results: A repeated measure ANOVA revealed a significant treatment effect for accuracy on the
3-back [F (24) = 8.118, p=.002, n2=.404]. Post-hoc paired sample t-tests uncovered a significant
improvement in accuracy from baseline and the exercise condition [t (25) = 2.605, p=.015, d =
.511] and an improvement in accuracy from baseline and the nicotine inhalation condition [t (25)
= 3.447, p = .002, d = .676]. Non-significant differences were observed between the two
treatments groups [t (25) = .892, p=.381, d=.175]. A repeated measures ANOVA revealed a nonsignificant treatment effect for RT on the 3-back [F (24) = .428, p=.772, n2=0.021].
Conclusion: Exercise is pragmatically as effective as nicotine in improving acute working
memory accuracy without a compromise in reaction time.
Keywords: Smoking, moderate intensity exercise, cognition, working memory.
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Chapter one: Background
Tobacco has numerous health consequences including but not limited to: cancer, heart disease,
chronic lung diseases, pneumonia, and stroke (Stanhope et al., 1964). Tobacco continues to be
the leading preventable cause of death to Canadians (Reid, Hammond, Rynard, & Burkhalter,
2015). Despite the deleterious health consequences, approximately 16 percent of Canadians
continue to partake in smoking behaviours (Statistics Canada, 2016). Among these Canadians,
Statistics Canada (2016) has found that males are more likely to be smokers than females; the
highest rates of smoking in the country by province are in Nunavut, Northwest Territories, and
the Yukon; and the lowest prevalence of smokers by province are British Columbia, Manitoba
and Ontario. According to the Canadian Cancer Society (2017) tobacco smoking was
responsible for over 20,000 deaths in Canada in 2016. In addition to the negative health
outcomes posed to the smoker, smoking also harms the public through second- and third-hand
smoke. Second-hand smoke can be defined as smoke that has been exhaled by the smoker or
burned from the end of a cigarette, while third-hand smoke is defined as the smoke residue and
gases that are left after a cigarette has been smoked, for example trapped within clothing and
furniture (Protano & Vitali, 2011). Many of the health consequences associated with smoking
(such as: ischaemic heart disease, lower respiratory infections, asthma, and lung cancer) are also
associated with second-hand smoke (Öberg, Jaakkola, Woodward, Peruga, & Prüss-Ustün,
2011). Children of smokers are especially susceptible to the detrimental health effects as 40% of
children worldwide are exposed to these passive cigarette smoking modalities (Ferrante et al.,
2013; Öberg et al., 2011).
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Smoking cessation can reduce the risk of the previously mentioned diseases for both the
smoker and public. Smoker’s feel the benefits of quitting within 12 hours, as they experience
improved lung function, blood circulation, and removal of carbon monoxide from the blood
(U.S. Department of Health and Human Services, 1990). The long-term effects from smoking
cessation include; decreased risk of coronary heart disease and strokes (same risk as non-smoker)
and risk of mortality reduced by 50% compared to current smokers (U.S. Department of Health
and Human Services, 1990). Many smokers wish to quit smoker (approximately 75%),
unfortunately most smokers who make a quit attempt relapse in the first eight days (Hughes,
Keely, & Naud, 2004; Mullins & Borland, 1996). Furthermore, the success of unassisted quit
attempt is very low, as the successfulness of the smoker remaining smoke free by the one-year
mark is 3-5% (Centers for Disease Control and Prevention, 2011). Smoking has been known to
be highly addictive due to its psychoactive ingredient nicotine (Benowitz, Ferrence, Slade,
Room, & Pope, 2000).

1.1 Predisposition to nicotine dependence
There are known predisposing factors to nicotine dependence including; genetic, demographic,
social, and psychological factors (Amos, Spitz, & Cinciripini, 2010; Hanson & Chen, 2007;
Lasser et al., 2000; Malouff, Thorsteinsson, & Schutte, 2006). To maximize the effectiveness of
new smoking interventions, these factors must be duly considered. These factors are explained
further below.
1.1.1 Genetic factors
The genetic components involved in nicotine dependence should be acknowledged (Amos et al.,
2010). For current smokers, there are certain genes that are associated with increased cigarettes
smoked per day. The cholinergic receptor nicotinic alpha (CHRNA) genes (CHRNA3, CHRNA5
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and CHRNB4) and cytochrome-P450 2A6 (CYP2A6), in particular, have been shown to play a
significant role in the number of cigarettes smoked per day. The CHRNA genes encode for
acetylcholine receptors (including nAChR) which are important sites of binding for
acetylcholine—a neurotransmitter involved in processes such as arousal and attention. These
receptors play a critical role in nicotine dependence, as nicotine acts as an agonist at nAChRs.
The more receptors available, the stronger the effects felt from nicotine (Amos et al., 2010).
CYP2A6 dictates an individual’s ability to metabolize nicotine (Amos et al., 2010). The speed at
which one metabolizes nicotine is related to the cigarettes smoked per day, such that the faster
you metabolize the substance, the more cigarettes the individual would consume to ensure
optimal nicotine levels in the blood would be achieved (Henningfield, London, & Pogun, 2009).
Furthermore, Furberg and colleagues (2010), indicates that dopamine B-hydroxylase (DBH;
catalyzes the conversion of dopamine to norepinephrine), plays a role in cessation success, but
limited research to date has been focused in this area (Furberg et al., 2010). Thus, focusing on
the genetic factors involved in nicotine metabolism, dependence, and cessation, may provide
additional information for intervention development.
1.1.2 Demographic and social factors
Certain demographic factors are thought to play a role in cigarette consumption. Factors
including having lower socioeconomic status, being male, having less education, engaging in
high levels of alcohol consumption, and high levels of caffeine consumption, have all been
identified as factors associated with greater tobacco usage (Hanson & Chen, 2007; Matarazoo &
Saslow, 1960). Several social influences also play a role in the rates of an individual’s smoking
behaviour. For example, having a parent that smokes, being a member of social groups that
engage in smoking, as well as social environments such as place of work (Ham et al., 2012).
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Moreover, females tend to use cigarettes to control their weight more often than males (Pirie,
Murray, & Luepker, 1991). Finally, low levels of brain-derived neurotrophic factor (BDNF) have
been linked to smoking initiation (Amos et al., 2010). More specifically, BDNF plays a role in
the neurobiological processes associated with socially stressful and anxiety-inducing situations;
which is thought to be how the protein is implicated in smoking initiation. Due to these
influences, demographic and social factors should be taken into consideration when developing
an intervention for smoking cessation.
1.1.3 Psychological factors
Several psychological factors have been associated with increased smoking behaviours. Malouff
and colleagues (2006) conducted a meta-analysis on personality traits (the five-factor model) that
are linked to smoking behaviour. They found that smokers tend to have high openness, low
conscientiousness, high extraversion, low agreeableness and high neuroticism. These results
have since been replicated by a 2007 review examining the personality traits of extraversion,
neuroticism, and smoking status (Munafò, Zetteler, & Clark, 2007). Individuals with these
particular personality traits should be considered at risk for developing a smoking behaviour.
An array of psychological/mental disorders have also been linked to increases in smoking
behaviour (Lasser et al., 2000). This population-based prevalence study concluded that
individuals suffering from mental illness are about twice more likely to be smokers than
individuals whom are not suffering (Lasser et al., 2000). Some of the most documented mental
illnesses linked with smoking behaviour are substance use disorders (especially alcohol use
disorder), depression, anxiety, and schizophrenia (Fergusson, Goodwin, & Horwood, 2003;
Gehricke et al., 2007; Kalman, Morissette, & George, 2005; Kelly & McCreadie, 2000). A
possible driving force behind this relationship is the concept of self-medication (Gehricke et al.,
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2007). The concept of self-medication is when a morbidity arises, an individual will seek and use
substances that are not recommended by their doctor but, rather, chosen by themselves. The
added disorder on top of the nicotine use-disorder can be termed co-morbidity. These comorbidities may increase the difficulty of attempting to quit and remaining abstinent.

1.2 Mechanisms behind nicotine administration
1.2.1 Mechanism of nicotine upon administration
The most effective way to administer nicotine is through the route of inhalation, with the
potential benefits of the substance being achieved in under 10 seconds (Caldwell, Sumner, &
Crane, 2012). The effects of nicotine in the body are related to the activation of cholinergic
pathways. Once nicotine is administered into the body it mimics the binding of acetylcholine to
the nicotinic acetylcholine receptors (nAChRs) throughout the brain and causes a release of
many neurotransmitters (Benowitz, 2008). The neurotransmitter most commonly related to the
euphoric and self-administration effects of nicotine is dopamine (Benowitz, 2008). The
rewarding effects of nicotine is in part due to the binding of nicotine on the dopaminergic
neurons (which have nAChRs on them) in the ventral tegmental area (VTA) which in turn
releases the neurotransmitter dopamine in the VTA and nucleus accumbens (Clarke, Fu,
Jakubovic, & Fibiger, 1988; Di Chiara, 2000). The release of dopamine in these areas of the
brain have been shown to produce reinforcement effects for individuals to continue seeking the
behaviour (Benowitz, 2008). Gamma-Aminobutyric acid (GABA) also plays a large role in the
reuptake of dopamine, but when nicotine is administered, GABA’s ability to down regulate
dopamine is hindered. Hence, causing larger amounts of dopamine to be in the system for a
longer period of time, producing longer euphoric effects (Mansvelder, Keath, & McGehee,
2002). Benowitz (2008) also indicates that many of the other neurotransmitters released have
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acute benefits to an individual. For example, acetylcholine is responsible for increases in arousal
and cognitive ability, norepinephrine is responsible for increases in arousal and suppression of
appetite, glutamate is responsible for learning and memory enhancement, serotonin is
responsible for decreases in appetite, and gamma-Aminobutyric acid (GABA) is responsible for
reduction of anxiety and tension. Due to the rewarding effects felt from many of these
neurotransmitters, individuals can become addicted to nicotine.
1.2.2 Self-administration, condition place preference, and positive reinforcement
Nicotine has repeatedly been identified as a drug that many animals and humans will selfadminister (Corrigall & Coen, 1989; Slifer, 1983). Nicotine has also been shown to produce a
conditioned place preference (rodent will prefer the location where administration of the
psychostimulant took place) in the rodent model reinforcing the motivational effects of the
substance (Le Foll & Goldberg, 2005; Vastola, Douglas, Varlinskaya, & Spear, 2002). Cigarette
smoking has been related to positive reinforcement for behaviour initiation and continuation
(Jarvik, 1991). The positive reinforcing effect of nicotine are related not only to the euphoric
effects but also the cognitive enhancing effects of the drug through many of the
neurotransmitters discussed previously (such as; acetylcholine, dopamine, and GABA; (Jarvik,
1991; Watkins, Koob, & Markou, 2000). The self-administration, the condition place preference,
and positive reinforcement provides further evidence of the rewarding effects of nicotine.
1.2.3 Nicotine use disorder
Mild-Substance use disorder (which would include nicotine) is defined by the Diagnostic and
Statistical Manual of Mental Disorders (DSM-5) by two-three symptoms, moderate use as fourfive symptoms and severe as six or more symptoms, out of a possible 12 symptoms in a 12
month period. These symptoms include; hazardous use, social/interpersonal problems related to
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use, neglected major roles to use, legal problems, withdrawal, tolerance, use larger
amounts/longer, repeated attempts to quit/control use, much time spent using,
physical/psychological problems related to use, activities given up to use, and cravings (Hasin et
al., 2013). As the disorder increases from mild to moderate to severe, it has been documented
that it is harder to quit the behaviour (Hasin et al., 2013).
1.2.4 Withdrawal symptoms
During cessation of smoking, nicotine withdrawal symptoms in rats and humans have been
documented (Hughes & Hatsukami, 1986; Malin et al., 1992). Within the rat model, a variety of
symptoms consistently present themselves during nicotine withdrawal, including; behavioural
signs (teeth-chattering, gasps, tremors, and ptosis), decreased activity counts, and weight gain
(Malin et al., 1992). The human model provides further evidence of withdrawal symptoms from
nicotine (Hughes, Higgins, & Bickel, 1994). In humans, these symptoms include anxiety, issues
sleeping, depression, difficulty concentrating, impatience, irritability, restlessness, decreases in
heart rate, and weight gain (Hughes et al., 1994; Hughes & Hatsukami, 1986). The mitigation of
these withdrawal symptoms seems like a prospective way to increase the successfulness of quit
attempts and should be taken into consideration during intervention development.
1.2.5 Acute effects of nicotine on cognition
The acute effects of nicotine on cognition in non-deprived (less than 2 hour abstinent) smokers
and non-smokers has been studied in depth (Heishman, Kleykamp, & Singleton, 2010). Many
different cognitive domains were examined, such as fine motor, alerting attention, orienting
attention, short-term episodic memory, long-term episodic memory, and working memory. The
effect sizes for these categories are as followed; fine motor tasks g = 0.16, alerting attentionaccuracy and reaction time (RT) g = 0.34, orienting attention – accuracy g = 0.13, orienting
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attention –RT g = 0.3, short-term episodic memory – accuracy g = 0.44, long-term episodic
memory –accuracy g = 0.17, working memory-accuracy of g = -0.11, and working memory RT
of g = 0.34. It is important to note that these effect sizes are pooled for both smokers and nonsmokers, a variety of tests and different nicotine doses were used to examine the same category
which could lead to differentiating results. The analysis examined the non-smokers and smokers
separately when applicable, and the working memory effects of nicotine on a non-smoking
population are as followed; for a non-smoking population the working memory-RT effect size
was g = 0.31 whereas, the effect size for working memory-accuracy was g = -0.11 (Heishman et
al., 2010). The negative effect found for accuracy may be attributed to a relatively large nicotine
dose given to the non-smoking participants (Heishman & Henningfield, 2000). In comparison,
the smokers produced a medium effect of g = 0.45 for working memory-RT. The lack of working
memory-accuracy measures in the meta-analysis made it implausible to calculate an effect size
for the smoking population. Currently the non-smoking, non-deprived literature provides
evidence for a positive effect of nicotine on working memory (Ernst et al., 2001; Heishman et al.,
2010; Houlihan, Pritchard, & Robinson, 2001). Finally in a nicotine-deprived paradigm, it has
been shown that after a 12 hour abstinence, working memory deficits are seen (p < 0.01; Myers,
Taylor, Moolchan, & Heishman, 2008), and administration of nicotine, once in a deprived state
has significant decrease in errors rates on the 3-back task (t = 4.0, df = 5, p < 0.05; Xu et al.,
2006). It is clear throughout the literature that nicotine plays a role in working memory tasks
including an enhancing effect for non-smokers, non-deprived smokers, and nicotine-deprived
smokers.
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1.2.6 Mechanism behind nicotine effects on cognition
The ability of nicotine to improve cognition may be due to the interaction between nicotine and
the presynaptic nAChR receptors in the brain which facilitates the release of acetylcholine
(ACh), dopamine, serotonin, glutamate, and γ-aminobutryic acid (Wannacott, 1987). These
neurotransmitters are associated with learning and memory (Martin & Aceto, 1981). Specifically
in a rodent model, the α7 and α4β2 nicotinic receptors found in the hippocampus play an integral
role in the cognitive effects from nicotine (Rezvani & Levin, 2001). Additionally, nicotine also
exerts its effects on hippocampus by increasing hippocampal long-term potentiation (Hamid,
Dawe, Gray, & Stephenson, 1997) and increasing hippocampal synaptic activity (Gray, Rajan,
Radcliffe, Yakehiro, & Dani, 1996). These mechanistic pathways provide insight into the
importance of the hippocampus for nicotine’s effects on memory.
Several other areas of the brain are thought to be involved in nicotine’s effects on
attention and memory such as the prefrontal cortex, partietal cortex, and thalamus (Brody, 2006;
Henningfield et al., 2009; Rezvani & Levin, 2001). This is thought to be due to the high density
of nAChR found in these areas of the brain. Himmelheber, Sarter, and Bruno (2000) explored the
neurotransmitters released during sustained attention in a rodent model and found that within the
prefrontal cortex larger amounts of acetylcholine are released. The effects of nicotine produce
similar neurotransmitters, hence may play a role in sustained attention.
Miniussi and Ruzzoli (2013) explain that cortical excitability is a possible biomarker for
cognitive function. The administration of nicotine leads to higher cortical excitability which is a
possible biomarker for cognitive enhancement in a non-smoking model (Grundey et al., 2015).
Cortical excitability has been documented as a primary mechanism for the improvements seen on
a working memory task post-nicotine administration (Grundey et al., 2015). In situations where
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nicotine is administered over a chronic period, many of the cognitive performance systems (i.e.,
cortical excitability and acetylcholine release) are down-regulated as the body is used to the
psychostimulant being administered (Li, Semenova, D’Souza, Stoker, & Markou, 2014). Hence,
the down-regulation of these systems may be causing withdrawal symptoms including cognitive
defects which can be eliminated by administration of nicotine (Lang, Hasan, Sueske, Paulus, &
Nitsche, 2008).
1.2.7 Acute effects of exercise on cognition
Chang and colleagues (2012) completed a meta-analysis on the effects of exercise on cognition
and concluded that exercise has a positive effect on cognition during (d = 0.101), immediately
following (d = 0.108) and after a delay (d = 0.103). These effect sizes are pooled for the primary
outcome but do not consider the intensity of exercise or duration of exercise) and therefore
should be interpreted with caution. After further investigation, there seems to be a “sweet spot”
of completing at least 11-20 minutes of exercise (d = 0.262) and that moderate intensity exercise
produces the largest cognitive effects at all time points except after a delay (during d = 0.193,
immediately following exercise d = 0.120, and after a delay following exercise d = 0.202) where
high intensity exercise provided a larger effect (d = 0.465) only after a delay (Chang et al.,
2012). More specifically, exercise has been studied in respects to working memory (Pontifex,
Hillman, Fernhall, Thompson, & Valentini, 2009). It appears that aerobic exercise, provides
decreased reaction times immediately following exercise and 30-minutes post exercise on a
working memory task providing evidence for working memory enhancement (Pontifex et al.,
2009). Currently, the effects of acute exercise on working memory in smokers is unknown.
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1.2.8 Mechanism behind aerobic exercise effects on cognition
The mechanistic pathway for the cognitive enhancement seen by moderate intensity exercise is
still in question. Mechanisms such as; increased cerebral blood flow, increased brain-derived
neurotrophic factor (BDNF), general increases in arousal, and finally increases in
neurotransmitter release in brain regions associated with cognitive functions have all been
suggested (Chang et al., 2012; Colcombe & Kramer, 2003; Kamijo, Nishihira, Higashiura, &
Kuroiwa, 2007). More specifically, the mechanistic pathways thought to play a role in working
memory are; increases in BDNF to the hippocampus (Hillman, Erickson, & Kramer, 2008;
Vaynman, Ying, & Gomez-Pinilla, 2004) and increased cerebral blood flow to areas including
the hippocampus which would play a role in delivering oxygenated blood to optimize the
structure (Delp et al., 2001). There is evidence to suggest aerobic exercise is unique in its ability
to enhance and optimize cognitive functioning in such a way that it is a promising element to use
in populations that face challenges to cognition (e.g. effects of withdrawal felt by smokers on
working memory)
1.2.9 Exercise and nicotine on working memory in non-smokers
Previously, Guirguis (2016) examined the effects post-exercise and post-nicotine on a working
memory task in a non-smoking young adult population (N = 23). Working memory is a
component of cognition worth focusing on as it allows for complex decision making and goaloriented behaviour which is important for sport and academic achievement (Alloway & Alloway,
2010; Baddeley, 1998; Bryan & Luszcz, 2010). Guirguis utilized a within-subject
counterbalanced design with two experimental treatment groups; a moderate intensity exercise
group and a nicotine administration group. The moderate intensity exercise group completed 20
minutes of moderate intensity exercise including a three minute warm-up and a two minute cool-
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down. Moderate intensity exercise was calculated using 45-68% of maximum heart rate (MHR =
220-age). The participants in the nicotine group were given two pieces of nicotine polacrilex
gum (2 mg per piece). The individuals where then instructed to chew the gum once every three
seconds for standardization. The main outcome of working memory was the 3-back task,
whereas the secondary outcomes included 0-back, 1-back, 2-back. The results from this work
showed a significant improvement in 3-back accuracy (t (22) = 4.36, p < 0.001, η2 = 0.46) and
reaction time (t (22) = 3.20, p = 0.004, η2 = 0.31) after exercise. The results also showed a nonsignificant improvement in 3-back accuracy (t (22) = .866, p = .396, η2 = 0.03) and a significant
improvement in reaction time (t (22) = 3.099, p = .005, η2 = 0.30) post-nicotine administration.
The treatment groups did significantly differ from one another in 3-back accuracy (t (22) = 2.57,
p = 0.012, η2 = 0.25), but did not significantly differ from one another in RT post condition (t
(22) = 0.087, p = 0.931, η2 = 0.00). The cognitive boost of exercise seen in this study provides
non-smokers with a safe and healthy alternative to nicotine (smoking) for improving cognitive
performance. Determining whether these findings can be replicated using smokers seems
warranted.

1.3. Purpose and Hypothesis
1.3.1 Purpose
The purpose of the study was to examine the cognitive performance effects of a 20-minute bout
of moderate intensity exercise compared to nicotine administration on non-deprived smokers.
1.3.2 Hypothesis 1
In comparison to a baseline working memory assessment, post-exercise and post-nicotine will
show an enhancement in working memory performance.
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1.3.3 Hypothesis 2
There will be no post treatment differences in working memory performance between nicotine
inhalation group and the moderate intensity exercise group
1.3.5 Implications of this study
If the above hypotheses are supported this research will allow for further investigation into the
possible effects different modalities of exercise (e.g., resistance training) have on cognitive
performance in smokers. Furthermore, positive findings will provide a framework for the design
and implementation of safe and effective (a) exercise strategies to boost cognition, and (b)
exercise-aided smoking cessation programs.
1.4 Ethics Statement
The experimental procedure was approved by the Western University Health Science Research
Ethics Board (HSREB) and met the standards of the Declaration of Helsinki. Each participant
read the letter of information, which included the tasks involved with the study, and the risks
associated with partaken in the interventions prior to providing written consent. (See Appendix
A).

Chapter two: Methods
2.1 Participants
A sample of 26 adults was recruited for the study. The inclusion criteria consisted of: 1) being a
smoker (at least five cigarettes a day self-reported, and verified with a carbon monoxide (CO)
reading of >10 P.P.M. upon arrival), 2) aged 18-64 years, 3) having no contraindications to
physical activity, 4) having no contraindications to nicotine, and 5) being right handed as it may
be a moderating factor for reaction time (Kalyanshetti & Vastrad, 2013). Participants were
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excluded for the following reasons: 1) self-reporting a mental illness, 2) being pregnant or
breastfeeding, 3) self-reporting chronic obstructive pulmonary disease (COPD), 4) consumption
of alcohol or drugs in the last 24 hours as it plays a role in the metabolism of nicotine, 5)
consumption of caffeine (more than half a cup of coffee) as it plays a role in the metabolism of
nicotine, and 6) self-reporting other major health complications (i.e., recent heart attack).

2.2 Design
The study utilized a randomized counterbalanced crossover design in which each participant was
randomly assigned to the order of the treatment but completed both treatments (i.e., exercise and
nicotine; see Figure 1).

2.3 Primary outcome
2.3.1 Working memory
Working memory was measured through the use of the n-back task (see figure 2). The n-back is
an effective measure of working memory as it uses both short-term recognition of stimuli and an
operation upon recognition of such stimuli (Baddeley, 1998). The n-back examination consisted
of four different working memory cognitive loads; 0-back, 1-back, 2-back, and 3-back. The task
was performed on a portable computer in the psychological assessment suite of the Exercise and
Health Psychology Laboratory in isolation. The task was performed on the software Millisecond
and the program INQUISIT 4.0.8.0. The individuals would complete a practice phase (scoring a
minimum of 75% accuracy on each test) before completing the evaluation. Consistently
achieving at least 75% accuracy was deemed appropriate for mitigating the practice effect in the
n-back task in the non-smoking population (Guirguis, 2016). During the evaluation, the
individuals would complete the 0-back, 1-back, 2-back, and 3-back, three times in random order.
The evaluation took approximately 10-minutes. The version of the n-back used consisted of letter
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stimuli that would appear on the portable computer screen. Each letter stimulus was presented
upon the computer screen for 500 milliseconds (ms), followed by a 2000 ms interstimulus (blank
screen). The number of stimuli changed depending upon the working memory load, for example;
0-back = 48 letters, 1-back = 48 letters, 2-back = 50 letters, 3-back = 54 letters. A correct
response would be one that appeared “N” items back in the sequence in which a participant
would press the letter A on the keyboard using their right hand as soon as a target appeared and
was recognized as a correct response. In the 0-back working memory load, the target letter is
given prior to the assessment, for example, the program will show a target letter “the target is
W”, and hence every time a “W” appears on the screen the individual should press “A”. In the 1back working memory load, a correct response would be if matching letters are consecutive, for
example “F” “interstimulus” “F”. In the 2-back working memory load, a correct response would
be if a letter matched a previous letter that appear 2 back in the sequence, for example “T”
“interstimulus” “X” “interstiumlus” “T”. In the 3-back working memory load, a correct response
would be if a letter matched a previous letter that appear 3 back in the sequences, for example
“M” “interstimulus” “P” “interstimulus” “T” “interstimulus” “M” (see Figure 2). For each
condition both accuracy (percent of errors) and reaction time (in ms) were collected. The 3-back
letter condition was treated as the primary outcome measure as it is most sensitive to behaviour
and medication effects (Loughead et al., 2009). Furthermore, the 3-back letter condition has been
shown to be sensitive to exercise in a non-smoking population (Guirguis, 2016; Loughead et al.,
2009). Finally, participants were told to answer as fast and accurate as possible.
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2.4. Other outcomes
2.4.1 Fagerström test for cigarette dependence
Self-reported cigarette dependence was measured through the Fagerström Test for Cigarette
Dependence (Fagerström, 2012). The questionnaire is composed of six-items, cumulatively
scored from 0-10. Once summed, nicotine dependence is categorized as follows; very low = 0-2,
low = 3-4, medium = 5, high = 6-7 and very high = 8-10 (see Appendix B). The Fagerström Test
for Cigarette Dependence has been shown to be valid and reliable measure of cigarette
dependence (Etter, 2005) .
2.4.2 Physical-activity readiness questionnaire
The nine-item physical-activity readiness questionnaire was administered prior to participating in
exercise. The questionnaire is verified by the Canadian Society for Exercise Physiology (2017)
to ensure participants were eligible for the exercise treatment. Each item has only two possible
responses; yes or no. If any participant answered yes to any of the items, the participant was
excluded from the study for safety reasons (see Appendix B).
2.4.3 Godin-leisure time exercise questionnaire
The Godin-Leisure Time Exercise Questionnaire was administered to determine current levels of
physical activity (Godin & Shephard, 1985; Shephard, 1997). The questionnaire includes fouritems, regarding the number of times in the last seven days participation in exercise for at least
15 minutes of uninterrupted light, moderate, or strenuous exercise (see Appendix B). The GodinLeisure-Time Exercise Questionnaire has been shown to be valid and reliable measure of leisure
time physical activity (Eisenmann, Milburn, Jacobsen, & Moore, 2002).
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2.4.4 Smoking history questionnaire
A four-item questionnaire created by the author was administered to assess smoking history (i.e.,
On an average day, how many cigarettes do you smoke?; see Appendix B).
2.4.5 Demographics
A three-item demographics questionnaire created by the author was administered to assess age
(to ensure proper heart rate for intensity of exercise), education, and sex (see Appendix B).
2.4.6 Pre-treatment questionnaire
A Pre-treatment questionnaire adapted from Guirguis (2016) was administered prior to
participation in any treatment. The questionnaire included questions regarding; consumption of
alcohol and drugs in the past 18 hours (to reduce cofounders), consumption of caffeine (to reduce
cofounders), and self-assessed ability to exercise (see Appendix B).
2.4.7 Vital signs
Vital signs (heart rate and blood pressure) were taken at multiple time points throughout the
entirety of the study. These were taken as a manipulation check to ensure the treatments were
received as intended. Heart rate was measured with the Polar RS100 heart rate device and blood
pressure was measured manually (see Appendix B).

2.5 Treatment
2.5.1 Moderate intensity exercise
Moderate intensity exercise was defined as 40-68% of heart rate maximum (heart rate maximum:
220-age). Moderate intensity exercise was utilized in this treatment, as it has been shown to be
the optimal intensity for cognitive enhancement and can be easily completed by untrained
individuals (Chang et al., 2011). The treatment consisted of 20 minutes of exercise including a 3-
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minute warm up and a 2-minute cool down. The speed and incline was manipulated throughout
the bout to ensure the participant was working at the proper intensity with the speed never
surpassing 3 miles per hour (to ensure ability to walk) and if further manipulation was needed to
ensure proper heart rate, the incline was adjusted. The treatment was completed on a Woodway
PPS treadmill (Woodway, Waukesh, WI) with heart rate monitored through a Polar RS100 heart
rate device.
2.5.2 Nicotine inhalation
The nicotine inhalation treatment was designed with an ecological approach. The treatment
consisted of smoking a cigarette to completion. Participants were provided with Belmont
Charcoal Filter cigarettes to smoke for free (every participants chose this option) or they could
choose to smoke a cigarette of their preferred brand. This ecological approach was designed with
the negative attitudes toward nicotine replacement treatments and the rate of delivery of the
psychoactive substance (Etter & Perneger, 2001).

2.6 Procedures
2.6.1 Recruitment
Recruitment was done through an advertisement poster posted on social media, websites (such as
kijiji.ca), and in print in many locations around London, Ontario (see Appendix A).
2.6.2 Screening
Upon contact from potential participants through email or telephone, initial screening by the
student investigator took place. This included reinforcement of the inclusion criteria and
informing them of the location of the Exercise and Health Psychology Laboratory.
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2.6.3 Study procedures
An overview of study procedures is illustrated in Figure 1. Prior to arrival for study, participants
were asked to keep consumption of coffee to half a cup the day of testing, abstain from alcohol
and drugs for at least 18 hours prior to testing, and smoke a cigarette of choice 30 minutes prior
to arrival (for standardization). Upon arrival to the Exercise and Health Psychology lab (located
in room 408 of the Arthur and Sonia Labatt Health Science Building at Western University)
participants were verified as smokers (based on the reading from the piCO+ Smokerlyzer being
greater than 10 parts per million (P.P.M.)), given the letter of information and signed the
informed consent form (see Appendix A). Participants then completed a demographic survey,
smoking history questionnaire, PAR-Q readiness for exercise (Canadian Society for Exercise
Physiology, 2017), Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985;
Shephard, 1997), Fagerström Test for Cigarette Dependence (Fagerström, 2012), and prenicotine or pre-exercise questionnaire. After establishing familiarity with the cognitive task,
baseline cognition performance was obtained through administration of the n-back task.
Immediately following baseline, participants were randomized into either the exercise treatment
condition or the nicotine treatment condition. Following the treatment a cognitive performance
was obtained through administration of the n-back task. Upon completion of the first treatment
(for example the exercise treatment) the participants would do the remaining treatment
conditions (in this case the nicotine treatment). Finally, after completing the last treatment
condition, a cognitive performance was obtained through the n-back task. Vitals (heart rate,
carbon monoxide reading, and blood pressure) were assessed at baseline and post treatments
(vitals were always taken in the seated position). After completion of the study, participants were
compensated $15.00.
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2.7 Statistical analyses
2.7.1 Sample size calculation
Due to the novelty of an exercise intervention in this population, an a priori power calculation
was completed for a nicotine intervention in a non-deprived state. Using G*Power software with
the power set at 0.8, the significance set at 0.05, and the effect size set at g = 0.45 (Faul,
Erdfelder, Lang, & Buchner, 2007; Heishman et al., 2010), a sample size of 26 individuals was
needed to detect this difference.
2.7.2 Manipulation check
To ensure the time (irrespective of treatment) did not play a role in the results, separate paired
sample t-test were conducted from treatment performed first to treatment performed second. To
ensure the order of the treatments did not play a role in the results separate repeated measures 2
conditions (exercise, nicotine) x 2 order (exercise treatment first or nicotine treatment first)
ANOVAs were conducted.
2.7.3 Fidelity check
Paired sample t-tests were conducted on vitals (HR and BP) from baseline to post-treatment.
This was to ensure that the treatments were received as planned.
2.7.5 Primary outcome
Two repeated measures one-way ANOVAs were conducted across the three treatment conditions
(i.e., baseline, exercise and nicotine) for both n-back RT and accuracy. Bonferroni corrected
paired sample post-hoc t-tests were conducted pending significant findings from the repeated
measure ANOVAs (from baseline to exercise treatment, baseline to nicotine treatment, and
exercise treatment to nicotine treatment). Alpha was set at 0.05.
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Chapter three: Results
3.1 Data reduction
Individual data were excluded based upon the following criteria: a RT < 150 ms and/or a RT that
was 2.5 standard deviation from the individuals mean (Miller & Low, 2000). Less than 3% of
total trials were excluded from the study.

3.2 Demographics
Sample size, demographic and descriptive statistics for the participants involved in the study can
be seen in Table 1.

3.3 Manipulation check
3.3.1 Accuracy
Four paired sample t-tests (from treatment completed first to treatment completed second) were
computed to detect a time effect (did participants do better on second assessment compared to
the first irrespective of treatment) for the 3- back (t (25) = .654, p = .519, d = .128), 2-back (t
(25) = .794, p = .435, d = .156), 1-back (t (25) = 1.065, p = .296, d = .210), 0-back (t (25) = .490,
p = 629, d = .096). Hence, no significant time effect was found. Four 2 conditions (exercise,
nicotine) x 2 order (exercise treatment first or nicotine treatment first) repeated measure
ANOVAs were conducted to examine the condition x order effect for the 3-back (F (24) = 1.103,
p = .304, η2 = .044), 2- back (F (24) = .346, p = .562, η2 = .014), 1-back (F (24) = 1.191, p =
.286, η2 = .047), and 0-back (F (24) = .045, p = .835, η2 = .002). Hence, no significant condition
x order effect was found, see Figure 3.
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3.3.2 RT
Four paired sample t-tests (from condition completed first to condition completed second) were
computed to detect a time effect (did participants do better on second assessment compared to
the first irrespective of treatment) for the 3-back (t (25) = 1.520, p = .141, d = .298), 2-back (t
(25) = .530, p = .601, d = .104), 1-back (t (25) = -.096, p = .924, d = -.019), 0-back (t (25) = .353, p = .727, d = -.069). Hence, no time effect was found. Four 2 conditions (exercise,
nicotine) x 2 order (exercise treatment first or nicotine treatment first) repeated measure
ANOVAs were conducted to examine the condition x order effect for the 3-back (F (24) = 6.309,
p = .019, η2 = .208), 2-back (F (24) = .681, p = .417, η2 = .028), 1-back (F (24) = .065, p = .800,
η2 = .003), and 0-back (F (24) = .001, p = .971, η2 = .000). Hence, a significant condition x order
effect was found for the 3-back in favor of receiving the nicotine condition first, see Figure 4.

3.4 Fidelity check
3.4.1 Exercise
A paired-sample t-test was conducted from baseline to post exercise condition for heart rate (t
(25) = -8.171, p< .0001, d= -1.6), systolic blood pressure (t (25) = -9.211, p < .0001, d = -1.81),
diastolic blood pressure (t (25) =.234, p = .817, d =.05) and CO readings (t (25) =.443, p =.661 d
= .09; see Figure 5). Significant change was found for heart rate and systolic blood pressure (all
increasing post-exercise treatment).
3.4.2 Nicotine
A paired-sample t-test was conducted from baseline to post nicotine condition for heart rate (t
(25) = -6.188, p <.0001, d = -1.21), systolic blood pressure (t (25) = -1.303, p =.205 d = -.26),
diastolic blood pressure (t (25) =-5.516, p<.0001, d = -1.08) and CO readings (t (25) =-3.909, p
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=.001, d = -0.77; see figure 5). Significant change was found for heart rate, diastolic blood, and
pressure and CO readings (all increasing post-nicotine treatment).

3.4 Primary outcome
Means and standard deviations for 3-back accuracy and RT can be found in Table 2.
3.4.1 3-back accuracy
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was significant (F (24) = 8.118, p =.002, η2 =.404). Paired sample post hoc t-tests
uncovered significant differences between baseline and the exercise condition accuracy favoring
the exercise condition (t (25) = 2.605, p =.015, d = .511). Significant differences were also found
from baseline accuracy to nicotine condition accuracy favoring the nicotine condition (t (25) =
3.447, p =.002, d = 0.676). Non-significant differences were observed between the exercise
condition accuracy and the nicotine condition accuracy (t (25) =.892, p =.381, d = .175; see
Figure 6).
3.4.2 3-back RT
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was non-significant (F (24) = .428, p = .772 η2 = .021; see Figure 7).

3.5 Secondary outcome
Means and standard deviations for 2, 1, 0-back accuracy and RT can be found in Table 2.
3.5.1 2-back accuracy
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise and
nicotine) was non-significant (F (24) = .388, p = .682, η2 =.031).
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3.5.2 2-back RT
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was significant (F (24) = 5.985, p = .041, η2 = .234). Paired sample post hoc t-test
uncovered a non-significant difference between baseline RT and exercise condition RT (t (25) =
.960, p = .346, d = .188). A significant difference was found from baseline accuracy to nicotine
condition RT in favour of the nicotine condition (t (25) = 2.693, p = .012, d = .528). A nonsignificant difference was observed between the exercise condition RT and the nicotine condition
RT (t (25) = 1.807, p = .083, d = .354).
3.5.3 1-back accuracy
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was non-significant (F (24) = .499, p = .613, η2 = .040).
3.5.4 1-back RT
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was significant (F (24) = 5.902, p = .008, η2 = .290). Paired sample post hoc t-test
uncovered a non-significant difference between baseline RT and exercise condition RT (t (25) =
2.614, p =.015, d = .513). A significant difference was found from baseline RT to nicotine
condition RT in favour of the nicotine condition (t (25) = 3.380, p= .002, d = .663). Nonsignificant differences were observed between the exercise condition RT and the nicotine
condition RT (t (25) = .479, p= .636, d = .094).
3.5.5 0-back accuracy
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was non-significant (F (24) = .262, p = .772, η2 = .021).
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3.5.6 0-back RT
A repeated measure ANOVA across the three treatment conditions (i.e., baseline, exercise, and
nicotine) was significant (F (24) = 4.677, p = .019, η2 = .20). Paired sample post hoc t-test
uncovered a non-significant difference between baseline RT and exercise condition RT (t (25) =
-1.480, p = .151, d = .290). A non-significant difference was found from baseline RT to nicotine
condition RT (t (25) = .781, p =.442, d = .153). Significant differences were observed between
the exercise condition RT and the nicotine condition RT in favour of the nicotine condition (t
(25) = 3.092, p = .005, d = .606).

Chapter four: Discussion
To the author’s knowledge, this is the first study to investigate the effectiveness of an
acute bout of moderate-intensity exercise versus smoking (nicotine) on cognitive performance
(i.e., working memory) in a smoking population. Participants underwent both treatments in a
randomized counterbalanced fashion. Our main finding showed significant improvement in
accuracy from baseline after both treatments. Reaction times did not significantly improve from
baseline to after treatments. Beyond theses general findings a number of specific issues warrant
commentary.

4.1 Accuracy
In accordance with my hypothesis, following the moderate intensity exercise intervention
a 15.72% increase in accuracy on the 3-back was observed. Similarly in the nicotine inhalation
group a 23.36 % increase in accuracy was observed. The differences between the moderate
intensity exercise group and the nicotine inhalation group were found to be non-significant and
only a mean difference of 1.35 errors was observed. Using a non-smoking model, Guirguis
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(2016) found 3-back accuracy in the exercise condition improved by 31.25% but only 6.5% in
the nicotine condition. This 26.4% net difference suggested that exercise was superior to nicotine
in enhancing cognitive performance (i.e., working memory). Taken together with the present
findings, exercise has a more positive effect on accuracy in non-smoking models. In contrast,
nicotine has a more positive effect on accuracy in smoking models. This raises the question why?
Participants’ fitness may, in part, help answer this question. Fitness seems to play a role
in exercises’ effect on cognitive performance (Chang et al., 2012) as highly fit participants
appear to benefit the most while less-fit participants might suffer adverse effects. This is because
unfit participants are more likely to fatigue quicker, which is associated with impaired cognitive
performance (Brown & Bray, 2015). Participants in the Guirguis study were self-selected
opening the possibility they exercise regularly whereas participants in the current study were
smokers who were likely less fit because they did not exercise regularly. This observation is
reinforced by the Godin Leisure-Time Exercise questionnaire time data collected from both
studies. In short, participants in the former study may have tolerated the 20 minutes of moderate
intensity exercise (45-65% HR max) better than participants in the current study, which in turn
led to less fatigue and superior cognitive performance.
An alternative reason for the differentiating results found between the current study and
the Guirguis study in terms of accuracy on the 3-back task may be due to the novelty of nicotine
administration in the non-smoking population of the Guirguis study. This may have contributed
to feelings of dysphoria (profound state of unease or dissatisfaction). Past research has shown
that nicotine-induced enhancement might be jeopardized as a consequence of dysphoria nonsmokers experience (Heishman, Snyder, & Henningfield, 1993; Hindmarch, Kerr, & Sherwood,
1990). Additionally, the route of administration (inhalation) may have provided an added benefit
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to the smoking population used the current study as it is the route of choice for smokers and
provides the most effect way of administering nicotine into the blood (Caldwell et al., 2012).
Finally, with both studies not collecting blood samples of cotinine (metabolized nicotine) it is
unclear whether the nicotine dose were uniform between the non-smoking and smoking
populations, which may also play a role in the cognitive effects.
Although past research has shown that the entire n-back protocol is sensitive to accuracy
change by both acute exercise (Tomporowski, 2003) and nicotine (Heishman, Kleykamp, &
Singleton, 2010), the primary outcome of the present study was the 3-back (the most difficult
and challenging task). Only the 3-back has been shown to be sensitive to behaviour and
medication effects (Loughead et al., 2009). When accuracy scores were examined on the 0, 1,
and 2-back as secondary outcomes no significant difference was found from baseline to either
treatment, or between treatments. These null findings confirm the poor sensitivity to detect
cognitive enhancing effects of lower cognitive loads associated the n-back assessments (i.e.,
tasks are too easy). This is further illustrated by the uniformly high accuracy baseline scores
which indicates a ceiling effect (see Table 2).

4.2 Reaction time (RT)
Opposite to my hypothesis, following moderate intensity exercise or nicotine inhalation
RT was not significantly reduced from baseline for the 3-back condition. Reaction time increased
from baseline after exercise by 7.16 ms whereas RT decreased from baseline after nicotine by
28.77 ms (see Table 2). This finding in not in line with previous literature. Past studies have
reported significant decreases in RT for both exercise (Chang et al., 2012, Guirguis, 2016) and
nicotine (Heishman et al., 2010; Guirguis, 2016). Both treatments in this study are known to
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increase arousal (McMorris, Sproule, Turner, & Hale, 2011; Parrott, 1994; Perkins, Grobe,
Epstein, Caggiula, & Stiller, 1993). Therefore, shorter RT is expected post-treatment.
The unexpected post-treatment results may be due to the condition x order interaction
effect found in the manipulation check analysis. This interaction effect provided evidence the
order that nicotine treatment was received played a role in RT (i.e., individuals receiving the
nicotine treatment first performed significantly better on the exercise treatment received second).
This suggests that the effect of nicotine carried over into the exercise treatment to decrease 3back RT. Put another way, there may be a delay in nicotine treatment effects on 3-back RT. A
plausible way to control for this would be to take cotinine (metabolized nicotine) samples
throughout the procedures to ensure the amount of cotinine in the blood is consistent during the
exercise treatment between groups. Additionally, expanding the length of the procedures to
ensure the treatment conditions are on separate days would have provided a certain “wash-out”
period long enough to ensure contamination from the treatment received first was not present.
This may however, be difficult to accomplish as a smoking population adds additional
recruitment/adherence issues that are not found in a general adult population(Sherman & Lynch,
2014).
With respect to the 2-back, those in the moderate intensity exercise condition had a 26.76
millisecond (ms) RT decrease from baseline that was found to be nonsignificant. Whereas, those
in the nicotine inhalation intervention showed a 74.36 ms RT decrease from baseline that was
found to be significant. No significant differences were found between the treatment groups. A
similar finding was shown in the 1-back assessment. Specifically, a non-significant RT decrease
was found from baseline after moderate intensity exercise (i.e., 71.47 ms); and significant RT
decrease was found from baseline after nicotine inhalation (i.e., 83.47 ms). No significant
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differences were found between treatment groups. For the 0-back, there was a non-significant
increase in RT from baseline following the moderate intensity exercise intervention (i.e., 32.34
ms). In contrast, there was a non-significant decrease in RT from baseline after nicotine
inhalation (i.e., 13.84 ms). A significant difference was found between conditions for the 0-back.
Overall, there was consistent evidence that nicotine positively affected RT. These findings are
more in line with past research which found significant decreases in working memory RT in nonsmoking and non-deprived smokers administered nicotine (Heishman et al., 2010; Guirguis,
2016). Why exercise did not perform as well as nicotine in reducing RT using a smoking model
remains unknown. It is possible that the nicotine treatment was producing a larger increase in
arousal in comparison to the exercise treatment in the smoking population but more research is
needed.

4.3 Speed-accuracy trade-off
Working memory tasks like the N-back provide accuracy and reaction time (RT) scores.
Although there is a well-known speed-accuracy trade-off effect (performing a task faster
jeopardizes its accuracy; Reed, 1973), this was not the case in either treatment as both showed
improvements in 3-back accuracy without RT being compromised (i.e., slowed down). The
author argues accuracy data are more important in these types of tasks. Performing a cognitive
task faster has little implication if accuracy is jeopardized. For example, it is more important to
get the correct answer on an exam than to finish quickly. With respect to the speed-accuracy
findings seen in the 2, 1, 0-back, post nicotine treatment decreases in RT did not negatively
affect accuracy scores.
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4.4 Strengths and limitations
The within counterbalanced crossover design used in the present study can be seen as a strength.
Utilizing participants as their own control eliminates the demographic variability between the
groups. The randomization among condition order allows for an order and a condition x order
effect to be detected, which aids in elucidating the stand-alone effects of each intervention.
Additionally, the baseline being anchored with no possibility of receiving it second or third
should be seen as both a strength and a weakness. As a strength, it allows a stable baseline
measure to be established and comparisons to be made to the treatments. As a weakness, it does
not provide a completely randomized paradigm that allows baseline to be free of contamination
from either treatment.
Another strength was that fidelity checks were in place throughout the study to ensure the
interventions were received as intended. For example HR, blood pressure, and CO readings were
taken pre and post both treatments. This allowed for objective measures to be taken to ensure the
exercise treatment was received as intended (as HR and systolic blood pressure increase with
exercise and the CO readings would stay consistent; Shahraki, Mirshekari, Shahraki, Shahraki, &
Naroi, 2012), as well as, providing an objective measures to ensure the nicotine inhalation
treatment was received as intended (as HR, diastolic blood pressure and CO readings increase
with nicotine; Ernst et al., 2001; Foulds et al., 1997).
A further strength was that an ecological approach to nicotine administration was used to
mimic the acute cognitive effects received by a smoker from a cigarette. The protocol allowed
individuals to smoke a cigarette of their choice (a premium cigarette Belmont Charcoal Filter
Regular was provided free of charge if preferred). As this increases the ecological validity of the
nicotine administration, the exact nicotine content in the blood would be varied as smoking
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topography plays a large role in nicotine uptake, which should be considered a limitation. Further
limitations include the generalizability of the study. These findings cannot be generalized to all
smoking population as the sample was taken only from London, Ontario and the surrounding
area. The cognitive assessment also only included the n-back assessment which has be validated
for a working memory assessment (Jonides et al., 1997) but does not include other cognitive
assessments such as; fast-counting, stroop task, or the go-no-go which should be examined.
Finally, more sensitive cognitive measures such as the anti-saccade task may provide a more
accurate comparison between an exercise treatment and a nicotine treatment in the smoking
population (Samani & Heath, 2018).

4.5 Future directions
The next logical step in this line of research would be to examine the cognitive deficits faced by
smokers who are nicotine deprived (i.e., abstain from smoking); and the possibility to replenish
these cognitive deficits with an exercise treatment. Beyond the first logical next step, alternative
future directions from this work include; separating treatment conditions to take place on
different days, implementing the protocol in a real life setting as oppose to a laboratory setting
for “real world” validity, examining the possibility of a cumulative cognitive benefit from
exercise and nicotine, examining the effects of exercise after a time delay, examining more of the
cognitive domains (as only working memory was examined), examining the possibility of
different modalities of exercise such as resistance training or yoga, and finally examining the
possibility of using other modalities of exercise as a means to tackle many co-morbidities faced
by smokers (i.e., depression, anxiety, schizophrenia, and additional addictions).
Utilizing a research design that would disentangle the effects felt from exercise alone and
nicotine alone on the 3-back assessment RT (places the treatment conditions on separate days)
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would further clarify the effects of the treatments on working memory. This is not without its
complications with recruitment and adherence in the smoking population that would have to be
addressed prior to conducting the experiment.
The next step of implementing this protocol into the “real world” (treatment facility)
would provide the needed validity for exercise to be used as a stand-alone/and or an adjunct to
traditional treatment for nicotine addiction. This could include group walking sessions or
exercise classes, as well as individual tailored sessions and the effectiveness of both should be
examined. The possibility of a cumulative cognitive benefit from exercise and nicotine should be
examined in a nicotine-deprived model with the use of NRT. This could provide insight into how
exercise may lengthen or attenuate the cognitive benefits seen from using NRT during a quit
attempt.
It is important to examine the timing effects that are produced from exercise in the
smoking population. This would be important to determine the longevity of the cognitive effects
felt from exercise. For example, if exercise provides a cognitive benefit 30-minutes post exercise
it may provide added incentive for an individual to utilize exercise as an adjunct for smoking
cessation.
Comparisons between the effects from nicotine administration and moderate intensity
exercise through examination of other cognitive domains (fine motor abilities, alerting attention,
orienting attention, and episodic memory) should be examined, as this study only focused on
working memory through the n-back task. Nicotine has been shown to have positive effects on
five other cognitive domains (fine motor abilities; d = 0.16, alerting attention-accuracy; d = 0.34,
alerting attention-RT; d = 0.34, orienting attention-RT; d = 0.3, and short-term episodic memoryaccuracy; d = 0.44; Heishman et al., 2010). If exercise could enhance these cognitive domains to
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the same extent as nicotine administration, it would provide added evidence of the utility of
exercise in the domain of smoking cessation.
The possibility of different modalities of exercise providing cognitive benefits in the
smoking population should also be examined. For example, if strength training and yoga are
deemed effective for cognitive replenishment it may provide a smoker attempting to quit
alternative avenues and variability to stay motivated to keep exercising.
Finally, examining the possibility of using exercise for populations with co-morbidities
that are associated with smoking such as; mental health (i.e., depression, anxiety and
schizophrenia), groups susceptible to higher rates of smoking (such as the indigenous people of
Canada), and individuals struggling with multiple addictions, is important. Smoking cigarettes is
often in conjunction with other mental health issues (Lasser et al., 2000) and if a harm reduction
approach was taken it is possible that exercise could help with many psychological and
physiological symptoms (Stathopoulou, Powers, Berry, Smits, & Otto, 2006), while decreasing
the number of cigarette smoked simultaneously. For example, certain populations such as the
indigenous people of Canada, smoke at higher rates than the rest of the Canadian population
(Statistics Canada, 2015). Additionally, the average body mass index (BMI) for the indigenous
people of Canada is also above national average (Statistics Canada, 2015). Thus, a moderate
intensity exercise intervention for smoking cessation may provide a spillover effect on obesity in
this at risk populations.

4.6 Conclusion
Exercise is pragmatically as effective as nicotine in improving acute working memory accuracy
without a compromise in reaction time. Exercise is recommended over nicotine inhalation as a
safer, healthy alternative for acute cognitive enhancement in smokers.
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Tables and figures
Table 1: Demographic and smoking behaviour variables
Variable
n

%

M (SD)

Age

26

-

34.8(12.1)

Male

14

54.8

Fagerström Test of nicotine dependence

26

-

4.9(2.4)

Cigarettes/Day

26

-

16(7.5)

Years smoking

26

-

16.3(11.1)

Approximate time of last cigarettes (minutes)

26

-

38.7(19.9)

Physical activity (weekly frequencies)

26

-

-

Strenuous

26

-

2.3(2.5)

Moderate

26

-

3.8(2.6)

Mild

26

-

5.1(2.4)

Total weekly leisure activity (METs)1

26

-

55.5(35.7)

26

-

-

Post-secondary achievement

12

46.1

-

High school diploma

8

30.8

-

None

6

23.8

-

Education

Note. METs= metabolic equivalents units.
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Table 2: Means, standard deviations and 95% confidence intervals for n-back assessment
Trial
M

SD

95% CI

3-back Error %

17.62

6.12

[15.26, 19.97]

3-back RT

782.24

162.24

[719.88, 844.60]

8.12

6.99

[5.43, 10.80]

651.95

117.55

[606.77, 697.14]

5.30

6.32

[2.87, 7.73]

591.92

127.65

[542.85, 640.99]

3.21

6.43

[0.74, 5.68]

479.29

75.59

[450.23, 508.34]

3-back Error %

14.85

6.92

[12.19, 17.51]

3-back RT

789.40

266.88

[639.04, 844.21]

7.12

6.11

[4.77, 9.46]

625.20

136.38

[572.77, 627.90]

4.05

4.79

[2.21, 5.89]

520.45

118.18

[475.02, 565.88]

3.63

5.32

[1.58, 5.67]

511.53

106.80

[450.23, 508.34]

13.50

6.95

[10.83, 16.72]

Baseline

2-back Error %
2-back RT
1-back Error %
1-back RT
0-back Error %
0-back RT
Exercise

2-back Error %
2-back RT
1-back Error %
1-back RT
0-back Error %
0-back RT
Nicotine
3-back Error %

50
3-back RT
2-back Error %
2-back RT
1-back Error %
1-back RT
0-back Error %
0-back RT

753.47

195.78

[678.21, 828.72]

8.00

7.55

[5.10, 10.90]

577.59

130.87

[527.29, 627.90]

3.81

4.41

[2.11, 5.50]

508.46

108.29

[466.83, 550.08]

4.19

6.27

[1.78, 6.60]

465.45

81.02

[434.31, 496.59]
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Figure 1: An overview of the study procedures.
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Figure 2: A visual representation of the different cognitive loads of the n-back task.
Figure taken from Braver, Cohen, Nystrom, Jonides, Smith and Noll (1997).
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3-back Accuracy Order Effect
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Figure 3: Comparison of the 3-back accuracy order effect. Condition A = Received exercise
treatment followed by nicotine treatment. Condition B = Received nicotine treatment followed
by exercise treatment. Error bars represent standard deviation.
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3-back RT Order Effect
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Figure 4: Comparison of the 3-back RT order effect. Condition A = Received exercise treatment
followed by nicotine treatment. Condition B = Received nicotine treatment followed by exercise
treatment. Error bars represent standard deviation.
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Manipulation Check
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Figure 5: Vitals between baseline, exercise and nicotine treatment conditions. Error bars
represent standard deviation. * = p < 0.05, all comparison for significance are from baseline to
post-treatment.
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3-back Accuracy
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Figure 6: Comparison of accuracy on the 3-back task at baseline, immediately following
exercise and immediately following nicotine administration. *= p <0.05, all comparisons for
significance are from baseline to post-treatment.
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3-back RT
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Figure 7: Comparison of RT on the 3-back task at baseline, immediately following exercise and
immediately following nicotine administration.
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Letter of Information and Consent Form
Project Title: The Acute Effects of Exercise and Nicotine on Cognition in Smokers
Principal Investigator
Harry Prapavessis, Ph.D. (School of Kinesiology, Western University)
Co-investigators
Matthew Fagan, M.A. (School of Kinesiology, Western University)
Siobhan Smith, M.A. (School of Kinesiology, Western University)
Wuyou Sui, Ph.D. (school of Kinesiology, Western University)
Letter of Information
Invitation to Participate
You are being invited to participate in a research study examining the acute effects that moderate
intensity exercise (a brisk walk) and nicotine inhalation (smoking) have on working memory in
the smoking population. Working memory can be thought of as a type of short-term memory that
allows one to make quick and accurate decisions about any information that has been presented
previously. You are being invited to attend three sessions at the Exercise and Health Psychology
Lab at Western University. The study has two phases embedded within it. The first phase
involves a baseline assessment of working memory as well as post intervention assessment of
working memory. The first phase is designed with a counter-balanced (each participant is given
both interventions) while the second phase is designed with a randomized trial (each participant
is only receives one of the two interventions) and will be done in a nicotine-deprived state (not
smoking for 12 hours). It is important to understand that randomization happens by chance and is
much like flipping a coin. The purpose of this letter is to provide you with the information
needed to make an informed decision about participating in this research. Please take your time
to read this letter and please do not hesitate to ask questions throughout. Please take note that this
is a student project. We hope to recruit 34 participants that are over the age of 18 years.
Purpose of this Study
The primary objective of this study is to examine the short-term effects of exercise and nicotine
on working memory of non-deprived and nicotine-deprived smokers.
Invitation to Participate in Research and Eligibility Criteria
You are being invited to take part in this research study because
•
•
•
•
•
•
•

Are over the age of 18 years
Smoke 5 cigarettes or more per day
Do not have Chronic Obstructive Pulmonary Disease
Are not an individual who is inhaler dependent
Do not have any cognitive problems
Are not pregnant
Do not have a medical condition that prevents you to exercise
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•
•

Do not have an orthopaedic limitation
Can read and write in English

Study Procedures
If you choose to participate in this study you will be asked to attend three sessions located at the
Arthur and Sonia Labatt Health Sciences Building (HSB 408) at Western University. The
sessions will be scheduled to your best convenience. The total time commitment of this study
155 minutes over a three day period. Below is a detailed description of the tasks you will be
asked to complete.
During this study you will be asked to complete
During your first session at the laboratory you will be asked to complete:
Time involvement = 70 minutes
- Surveys (Item-1)
• Demographic questionnaire (Item-a)
• Smoking history questionnaire (Item –b)
• Godin Leisure-Time Exercise Questionnaire (Item –c)
• Pre-exercise or pre-nicotine (Item-d)
• Fagerstrom Test for Nicotine Dependence (Item-e)
- A cognitive computer task – N-back (Item- 2)
- An intervention condition either: (Item-3)
i) Moderate Intensity Aerobic Exercise or
ii) Nicotine Inhalation
During your second session at the laboratory you will be asked to complete:
Time involvement = 35 minutes
- Surveys (Item-1)
• Pre-exercise or pre-nicotine (Item-d)
- An intervention condition, either: (Item -3)
i) Moderate Intensity Aerobic Exercise or
ii) Nicotine Inhalation group
- A cognitive computer task-N-back (Item-2)
Item-4: You are asked to abstain from alcohol for at least 18 hours prior to your laboratory
meetings and restricted to ½ cup of coffee
During your third session at the laboratory you will be asked to complete:
Time involvement= 50 minutes
- Surveys: (Item-1)
• Pre-exercise or pre-nicotine (Item-d)
- An intervention condition, either: (Item-3)
i) Moderate Intensity Aerobic Exercise or
ii) Cigarette smoking
-A cognitive computer task-N-Back (Item-2)
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Item-5: You are asked to abstain from alcohol for at least 18 hours prior to your laboratory
meetings and restricted to ½ cup of coffee. You are also ask to abstain from smoking
cigarettes or the use of any tobacco products for 12 hours prior to your laboratory visit.
Task descriptions
1) Provide demographic and smoking and exercise information
The surveys will include:
a. Demographic questionnaire (which asks you identifiable information concerning,
your age, email telephone number, and education)
b. Smoking history questionnaire (“What is the approximate date and time of the last
cigarette you have smoked?”)
c. Exercise behaviour in the last 7-days questionnaire (“In the last 7 days, how many
times have you completed mild intensity exercise for 15 minutes or more?”)
d. Pre-exercise/nicotine questionnaire will be filled out before completing either task
e. Fagerstorm Test for Nicotine Dependence (Information about your smoking
behaviour)
2) Participate in a cognitive computer task
A number of tasks have been used to measure aspects of cognitive functions (intellectual
processes by which one becomes aware of, perceives, or comprehends ideas). In our study, we
will be using an N-back computer task to measure working memory. The N-back task is a 5
minute task that displays a letter on a computer screen for an interval of 500ms, followed by a
1000ms blank screen interstimulus. You will have to click the left button of a computer mouse as
soon as a target appears. In the 1-back condition, the target is defined as a letter flashing that is
the same as the one preceding it. For example, “x, interstimulus, x” would be the target.
3) Take part in an intervention condition: i) Moderate Intensity Exercise or ii) Cigarette
Smoking
i) Moderate Intensity Exercise (You will complete a single, 20-minute bout of moderate
intensity aerobic exercise. Exercise consisted of a 2-minute warm-up, followed by 15
min of walking at a rate, which will allow you to reach 2/3 of your max heart rate,
and then a 3-minute cool down on a treadmill)
a. Vital signs (heart rate and blood pressure) will be recorded just prior to, and just
after the exercise is complete.
ii) Nicotine inhalation (You will smoke a cigarette of your choice in the 20 minute time
period allocated, at this time you will refrain from conversation)
a. Vital signs (heart rate and blood pressure) will be recorded just prior to, and just
after nicotine administration.
Note that you will perform both procedures (exercise, and nicotine inhalation) by being
randomized to one procedure first and then required to perform the other procedure on a separate
day.
4) Abstain from drinking alcohol/coffee for at least 18 hours
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We ask that prior to your laboratory visit you abstain from drinking alcohol and restrict to ½ a
cup of coffee for at least 18 hours.
5) Abstain from drinking alcohol/coffee for at least 18 hours
We ask that prior to your laboratory visit you abstain from drinking alcohol and restrict to ½ a
cup of coffee for at least 18 hours. We also ask if you could refrain from smoking cigarettes or
using any tobacco related products for at least 12 hours.
Diagram of the study overview

Possible Risks and Harms
Below are the documented side effects that are possible to experience while taking part in this
study. It is important to note it is possible, however unlikely that other not known side effects
may take place.
Exercise: There are some inherent risks of injury associated with exercise participation,
particularly among people who are not used to exercising. You may, for example, feel mild
muscle “tightness” or soreness that lasts for a couple of days, possible chest tightness when
exercising, or even death. To minimize the physical risks of exercise, proper warm-up/cool-down
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and stretching protocols will be performed by a trained exercise counsellor. Additionally, the
exercise program delivered will be tailored to your individual fitness level, and modified
according to your comfort level. Furthermore, you will only be allowed to participate in this
exercise program if you complete the PAR-Q (Physical Activity Readiness Questionnaire) forms
to ensure that it is safe for you to begin an exercise program. The exercise facilitator will be both
CPR and First Aid trained, and experienced in working with previously inactive populations. If
any physical or mental risks arise during the intervention, the Student Emergency Response
Team (SERT) will be available to provide immediate assistance. SERT will assist the exercise
supervisor until the 911 emergency services arrive. Should you have a minor injury while
exercising you will receive medical treatment onsite as necessary. A first aid kit and ice packs
will be available for minor injuries.
Smoking: There are some inherent risks of cigarette smoking that should be acknowledged.
Smoking can cause many types of cancers, heart disease, stroke, chronic obstructive pulmonary
disease, diabetes, as well as many others. Smoking has been shown to cause fertile issues for
women attempting to become pregnant. The acute effects of a cigarette include an increase in
heart rate, an increase in blood pressure, and an increase in the aoritic stiffness index.
Acute smoking denervation (12 hours): There are known withdrawal symptoms of cigarettes
including; nervousness, headache, increased appetite, dizziness, constipation, fatigue, irritability
and tobacco craving which all can be unpleasant.
Compensation
You will be compensated for your time. If you complete all three visits you will receive a 15
dollar gift card. Parking will also be free at the EHPL if you wish to drive to your sessions.
Do I have to take part?
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your future care. If you
decide to take part you will be given this Letter of Information to keep and be asked to sign the
consent form. If you withdraw from the study, you maintain the right to request that any data
collected from you not be used in the study. If you make such a request, all of the data collected
from you will be destroyed. Please contact the study co-investigators, Matthew Fagan, Siobhan
Smith, or Wuyou Sui if you wish to withdraw from the study.
Participation in other studies
If you are participating in another study at this time, please inform the study researchers right
away to determine if it is appropriate for you to participate in this study.
New findings
If, during the course of this study, new information becomes available that may relate to your
willingness to continue to participate, this information will be provided to you by the
investigator.
Are there any costs associated with participation?
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This study is covered by an insurance policy and if during the course of the study any injury
should occur which is not due to your fault or negligence, all medical expenses necessary to treat
such injury will be paid provided: a) you comply at all times with the study researcher’s
instructions b) you promptly report any such injury to the study researchers conducting the study,
and c) the expenses are not otherwise covered by your provincial health care. Financial
compensation for such things as lost wages, disability or discomfort due to this type of injury is
not routinely available. You do not waive any legal rights by signing the consent form.
Will information obtained in the study be confidential?
All the information you provide to the researcher will be kept in the strictest confidence. You
will be assigned an identification number and all data collected from you will be recorded and
stored on the Exercise and Health Psychology lab’s research (R’) drive, under this number only.
Study researchers will not have any way of connecting your data to you. All data will be stored
in coded form on computers accessible only to research staff in a secure office. You will not be
identified in any documents relating to the research. No information obtained during the study
will be discussed with anyone outside of the research team. If the results of the study are
published, your name will not be used.
Representatives of the University of Western Ontario Health Sciences Research Ethics Board
may contact you or require access to your study-related records to monitor the conduct of the
research. If we find information we are required by law to disclose, we cannot guarantee
confidentiality. We will strive to ensure the confidentiality of your research-related records.
Absolute confidentiality cannot be guaranteed, as we may have to disclose certain information
under certain laws.
Questions?
If you have any questions about your rights as a research participant or the conduct of the study
you may contact the Office of Research Ethics.
If you have any questions about the study, please contact the study co-investigators, Matthew
Fagan, Siobhan Smith or Wuyou Sui.
This letter is for you to keep. You will be given a copy of this letter of information and consent
form once it has been signed. If you have any concerns, please feel free to contact one of the
researchers below. You may request the general findings of this research study from the
researchers after the study is complete.
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Informed Consent
Study Title: The Acute Effects of Exercise and Nicotine on Cognition in Smokers
I have read the Letter of Information, had the nature of the study explained to me and I agree to
participate. All questions have been answered to my satisfaction. I will be given a copy of the
Letter of Information and consent form once it has been signed.
Consenting Signature:
Participant: ________________________________________________________
Please Print Name

Participant: ________________________________________________________
Please Sign Name

Date: ___________________

Please send me my overall conclusions from this research:

Yes □ No □

Researcher Signature: ________________________________________________________
Please Sign Name

Person obtaining informed consent:

_______________________________________
Please Print Name
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Recruitment Poster
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Sociodemographic Questionnaire

Date of Birth: ________/___________
MM

YYYY

Sex: Male or Female
Section A – Education

1. What is the highest degree you earned?
(Please check one)

 High school diploma
 College certificate
 Bachelor’s degree
 Master’s degree
 Doctorate
 Professional (MD, LLB, DDS)
 Other (specify:_____________________)
 None of the above
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Smoking History Questionnaire
1. On an average day, how many cigarettes do you smoke?
2. What is your preferred brand of cigarettes?

3. When was the approximate time of your last cigarette?
4. How many years have you been smoking?
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Physical Activity Readiness Questionnaire (PARQ)
1. Has your doctor ever said that you have a heart condition and that you
should only do physical activity recommended by a doctor?
a.

[ ]Yes

b.

[ ]No

2. Do you feel pain in your chest when you do physical activity?
a.

[ ]Yes

b.

[ ]No

3. In the past month, have you had chest pain when you were not doing
physical activity?
a.

[ ]Yes

b.

[ ]No

4. Do you lose your balance because of dizziness or do you ever lose
consciousness?
a.

[ ]Yes

b.

[ ]No

5. Do you have a bone or joint problem that could be made worse by a
change in your physical activity?
a.

[ ]Yes

b.

[ ]No
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6. Is your doctor currently prescribing drugs (for example, water pills)
for your blood pressure or heart?
a.

[ ]Yes

b.

[ ]No

7. Do you know of any other reason why you should not do physical
activity?
a. [ ]Yes
b. [ ]No
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Fagerström Test for Cigarette Dependence
Please circle one of the provided answers for each question
1) How soon after waking do you smoke your first cigarette?
a) Within 5 minutes
b) 5-30 minutes
c) 31-60 minutes
2) Do you find it difficult to refrain from smoking in places where it
is forbidden? e.g. Church, Library, etc.
a) Yes
b) No
3) Which cigarette would you hate to give up?
a) The first in the morning
b) Any other
4) How many cigarettes a day do you smoke?
a) 10 or less
b) 11-20
c) 21-30
d) 31 or more
5) Do you smoke more frequently in the morning?
a) Yes
b) No
6) Do you smoke even if you are sick in bed most of the day?
a) Yes
b) No
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Godin Leisure-Time Exercise Questionnaire
1. During the last 7 days, how many times did you do the following
kinds of exercise for more than 15 minutes during your free time (write
on each line the appropriate number)?
a) STRENUOUS EXERCISE (heart beats rapidly)
(e.g., running, jogging, hockey, football, soccer, squash, basketball,
cross country skiing, judo, roller skating, vigorous swimming, vigorous
long distance bicycling).
b) MODERATE EXERCISE (not exhausting)
(e.g., fast walking, baseball, tennis, easy bicycling, volleyball,
badminton, easy swimming, alpine skiing, popular and folk dancing).
c) MILD EXERCISE (minimal effort)
(e.g., yoga, archery, fishing from river bank, bowling, horseshoes, golf,
snow-mobiling, easy walking).
Times Per Week
_____ times
_____ times
_____ times

2. During the last 7-Day period (week), in your leisure time, how often
did you engage in any regular activity long enough that your heart would
beat rapidly (work up a sweat)?
1. Often _______ 2. Sometimes _______ 3. Rarely/Never _______
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ID:

. Date:
Pre-study eligibility form

Please circle one of the following answers to the questions.
1) Have you abstained from alcohol and drugs in the past 18 hours? YES
or NO
2) Have you limited your consumption to 1⁄2 cup of caffeine today?
YES or NO or N/A
3) Are you physically well enough to be able to perform 20 minutes of
moderate intensity exercise today? YES or NO
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Vital Sign Form
Baseline
BP:
HR:
CO reading:
Immediately follow nicotine treatment
BP after:
HR after:
CO reading:
Immediately following exercise treatment
BP:
HR:
CO reading:
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Curriculum Vitae for Matthew Fagan
EDUCATION
Degrees
•
•

Masters of Art (Thesis) in Kinesiology, Psychological Basis, Western University,
2016-Present
Bachelors of Arts Honors in Kinesiology, Western University, 2012-2016

TEACHING
Teaching Assistant
•
•

Kinesiology 3330, Lab in Exercise Physiology (2016)
Kinesiology 4433, Physiology of Exercise Training (2017)

FUNDING
•

Ontario Graduate Scholarship (OGS), 2017-2018

COMMUNITY AND VOLUNTEER ACTIVITES
•
•
•

VP Research; Canadian Cancer Society Research Bureau, Canadian Cancer Society
Research Institute.
Research discovery leader, SHAD.
Financial Committee; Canadian Obesity Network Student Meeting.
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symptoms. Spoken Science Series, London, Canada (2018). Oral.
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on Nicotine and Tobacco, Baltimore, United States (2018). Poster.
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Acute Effects of Exercise and Nicotine on Cognition in Smokers. Eastern Canada Sport
and Exercise Psychology Symposium, Kingston, Canada. (2017). Oral.

BROADCAST INTERVIEWS
•

Alternative methods to increase cognition in smokers. GradCast, 94.9 CHRW. (2018).

78

PUBLICTIONS
•
•
•

•

Fitzgeorge, L., Tritter, A., Fagan, M. J., Nagpal, T. S., & Prapavessis, H. (2018).
Informing population-specific smoking policy development for college campuses: An
observational study. Tobacco Prevention and Cessation. Submitted.
Siobhan Smith, Matthew James Fagan, Jordan Lesarge, Harry Prapavessis. (2018).
Standing and Dynamic Sitting in the University Classroom: A Real Possibility. Learning
Environments Research. Submitted.
Sui, Y., Smith, S., Fagan, M. J., Rollo, S., Prapavessis, H. (2018). The effects of
sedentary behaviour interventions on work-related productivity and performance
outcomes in real and simulated office work: A systematic review for consideration to.
Applied Ergonomics. Submitted.
Nagpal T. S., Fagan M. J., Prapavessis H, PhD. (2017). Treatment options for smoking
cessation in pregnant women: A narrative review. Medical Research Archives. 5(7).
Published.

